Activation of natural killer cells by rituximab in granulomatosis with polyangiitis

Activation of natural killer cells by rituximab in granulomatosis with polyangiitis

Abstract Objective In the last few years, anti-CD20 antibody rituximab profoundly changed the therapeutic landscape of granulomatosis with polyangiitis (GPA). Here, we investigated whether natural killer (NK) cells may play a role in rituximab’s mechanism of action in GPA. Methods B cell depletion,...

Full description

Bibliographic Details
Main Authors:	Doris Urlaub, Shuyang Zhao, Norbert Blank, Raoul Bergner, Maren Claus, Theresa Tretter, Hanns-Martin Lorenz, Carsten Watzl, Wolfgang Merkt
Format:	Article
Language:	English
Published:	BMC 2019-12-01
Series:	Arthritis Research & Therapy
Subjects:	Natural killer cells Rituximab B cell depletion Rheumatic diseases ANCA-associated vasculitis Granulomatosis with polyangiitis
Online Access:	https://doi.org/10.1186/s13075-019-2054-0

Similar Items

Granulomatosis with polyangiitis with severe lung involvement: efficacy of anti-B cell therapy with Rituximab
by: T. V. Beketova, et al.
Published: (2021-07-01)

Granulomatosis with polyangiitis: An atypical initial presentation
by: Catarina Vilaça Pereira, et al.
Published: (2022-01-01)

Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide
by: M. Benucci, et al.
Published: (2013-05-01)

COVID-19 in a patient with granulomatosis with polyangiitis: Management tactics
by: E. F. Iskhakova, et al.
Published: (2023-03-01)

Granulomatosis with polyangiitis – diagnostic difficulties?
by: Marta Madej, et al.
Published: (2014-11-01)

Submandibular salivary gland involvement in granulomatosis with polyangiitis
by: Mohamed F. Abdelghany, et al.
Published: (2020-01-01)

Severe ophthalmic manifestation in pituitary-involved granulomatosis with polyangiitis: a case report and literature review
by: Xia Zhang, et al.
Published: (2018-11-01)

Predictors of relapse in granulomatosis with polyangiitis: a multi-center study
by: Sara Safari, et al.
Published: (2022-10-01)

Multiple Cutaneous Manifestations in ANCA-Positive Eosinophilic Granulomatosis with Polyangiitis before and after Biologic Therapy: Clinical and Histopathologic Characterization of a Paradigmatic Case
by: Giorgia Carnicelli, et al.
Published: (2022-12-01)

Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis
by: Emilio Besada, et al.
Published: (2015-06-01)

Successful treatment with rituximab and plasmapheresis of renal involvement of eosinophilic granulomatosis with polyangiitis
by: Ryuichi Yoshii, et al.
Published: (2023-02-01)

Clinical forms of granulomatosis with polyangiitis
by: Marta Madej, et al.
Published: (2014-11-01)

COVID-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab)
by: T. V. Beketova, et al.
Published: (2018-06-01)

Trimethoprim-sulfamethoxazole prophylaxis during treatment of granulomatosis with polyangiitis with rituximab in the United States of America: a retrospective cohort study
by: Arielle Mendel, et al.
Published: (2023-07-01)

GRANULOMATOSIS WITH POLYANGIITIS: TREAT THE PATIENT NOT SYMPTOMS
by: Makharynska O. S., et al.
Published: (2018-07-01)

Granulomatosis with polyangiitis: a 17 year experience from a tertiary care hospital in Pakistan
by: Omar Irfan, et al.
Published: (2018-05-01)

COVID-19 in a Patient Treated for Granulomatosis with Polyangiitis: Persistent Viral Shedding with No Cytokine Storm
by: Pascale Daniel, et al.
Published: (2020-09-01)

The eye is a common site of granulomatosis with polyangiitis. A collaborative study
by: Rosanna Dammacco, et al.
Published: (2023-01-01)

Granulomatosis with Polyangiitis (Wegener Granulomatosis) Mimicking Infective Endocarditis
by: Imène Rachdi, et al.
Published: (2014-10-01)

Granulomatosis with polyangiitis
by: Zubayer Ahmad, et al.
Published: (2016-12-01)

CD27+CD38hi B Cell Frequency During Remission Predicts Relapsing Disease in Granulomatosis With Polyangiitis Patients
by: Anouk von Borstel, et al.
Published: (2019-09-01)

Worsening of posterior scleritis and orbital pseudotumor in a patient with granulomatosis polyangiitis with rituximab-A case report
by: Kalpana Babu, et al.
Published: (2020-01-01)

Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi
by: Sei Adachi, et al.
Published: (2022-02-01)

Serum B cell activating factor (BAFF) as a biomarker for induction of remission with rituximab in ANCA-associated vasculitis
by: Kazuyuki Tsuboi, et al.
Published: (2022-10-01)

CD4 cell count and CD4/CD8 ratio increase during rituximab maintenance in granulomatosis with polyangiitis patients
by: Emilio Besada, et al.
Published: (2016-09-01)

The variety of clinical manifestations in the course of granulomatosis with polyangiitis
by: Aleksandra Metelska, et al.
Published: (2022-08-01)

Granulomatosis with polyangiitis mimicking COVID‐19 pneumonia: A case report
by: Arjun Basnet, et al.
Published: (2023-10-01)

Neurologic Involvement in Granulomatosis with Polyangiitis: A Comparative Study
by: Seyed Behnam Jazayeri, et al.
Published: (2023-01-01)

Unexpected positive effects of rituximab and corticosteroids on COVID-19 in a patient suffering from granulomatosis with polyangiitis
by: Mansour Salesi, et al.
Published: (2021-01-01)

Rituximab therapy combined with methotrexate for severe necrotizing scleritis in a case of granulomatosis with polyangiitis
by: Somasheila I Murthy, et al.
Published: (2020-01-01)

A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis
by: Michele V. Quan, et al.
Published: (2018-11-01)

Atypical Presentation of Granulomatosis with Polyangiitis
by: Davide Giordano, et al.
Published: (2018-11-01)

Limited granulomatosis with polyangiitis presenting as an isolated lung lesion
by: Shameera Begum, et al.
Published: (2020-01-01)

Culture-negative subacute bacterial endocarditis masquerades as granulomatosis with polyangiitis (Wegener’s granulomatosis) involving both the kidney and lung
by: Peng Hui, et al.
Published: (2012-12-01)

The course and outcomes of COVID-19 in patients with ANCA-associated systemic vasculitis, receiving biological therapy (Rituximab, Mepolizumab): The results of the first 8 months of the pandemic
by: T. V. Beketova, et al.
Published: (2021-03-01)

Granulomatosis with Polyangiitis: Recurrence or Treatment Consequences?
by: Andreia Diegues, et al.
Published: (2021-04-01)

ASYMPTOMATIC COURSE OF LUNG DAMAGE IN GRANULOMATOSIS WITH POLYANGIITIS (WEGENER’S)
by: Tat’yana V Beketova
Published: (2014-03-01)

Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis
by: Michele Iudici, et al.
Published: (2016-10-01)

Relapsing granulomatosis with polyangiitis with severe lung and upper respiratory tract involvement successfully treated with rituximab
by: Anna Masiak, et al.
Published: (2017-08-01)

Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy
by: Dario Roccatello, et al.
Published: (2022-03-01)